Impact of insulin resistance, body mass index, disease duration, and duration of metformin use on the efficacy of vildagliptin
{{output}}
Introduction: The optimal stage for dipeptidyl peptidase-4 (DPP-4) inhibitor therapy in the course of type 2 diabetes mellitus (T2DM) is still under discussion, with often a perception that treatment with these agents may be less... ...
